Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.
As the takeover bid from Couche-Tard heats up, Seven & i Holdings announced a plan to split its business in two.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
UnitedHealth, CVS, and Cigna want FTC chair Lina Khan and two other officials recused from their case due to alleged biases.
Rio Tinto announced plans to acquire US lithium miner Arcadium for $6.7 billion, making it the world’s third-largest lithium miner.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Amazon’s patent to help doctors take better notes highlights the company’s massive bet on the healthcare space.
In another opportunity to beef up the bottom line, McDonald’s launches a chicken version of its iconic Big Mac in the US.
Fossil fuel producers and OPEC have rained on the IEA’s parade, offering wildly different projections for future energy demand.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.